Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Comprehensive Sickle Cell Disease Program of Greenville Health System
900 W. Faris Road, 2nd FloorGreenville, South Carolina, United States
Phone Web
Over the last 30 years, children with sickle cell disease (SCD) have seen drastic improvements in their survival and quality of life through a standardized approach to treatment, disease modification, and preventive care. Adults with SCD, on the other hand, have often found it difficult to access these types of services and end up experiencing a higher amount of disease-related complications. In order to meet the needs of all individuals with SCD in our community, regardless of age, we have created the Comprehensive Sickle Cell Disease Program of Greenville Health System.
Services provided:
• Patient-centered, compassionate care for children and adults with SCD
• Dedicated care team (social work, psychology, nursing, medical providers) providing outpatient and inpatient services
• Outpatient infusion program for delivery of pain medications, fluids, antibiotics, and blood transfusions
• Management of disease modifying medications, such as Hydroxyurea and Endari
• In-office stroke risk screening with Transcranial Doppler (TCD) Ultrasound
• Chronic RBC transfusion program with apheresis capabilities on-site
• Standardized transition program designed to educate support and adolescents as they move into the adult model of care
• Social work and case management services
• School Intervention Program (SIP)
• Access to local and national research protocols
Related Content
-
Men Living Well with Sickle Cell Guys Night OutMen with sickle cell disease open up can...
-
Progressive Loss of Brain Volume in Children with Sickle Cell Anemia: A Report from the Silent Cerebral Infarct Tran...Introduction: Neurological injury is a c...
-
Sohail Rana, MDDr. Rana is Professor of Pediatrics at H...
-
Multicenter COMPACT study of COMplications in patients with sickle cell disease and utilization of iron chelation th...BACKGROUND: Over the past few decades, l...
-
Emmaus Life Sciences, Inc. to present results of phase 3 study of endariTM (L-glutamine oral powder) at 59th America...Emmaus will present results of a Phase 3...
-
SCDAA News Advisory: SCDAA Statement on Exa-cel Gene TherapyOn October 31, 2023, the Food and Drug A...
-
Yale New Haven HospitalMedical teams at Yale New Haven Hospital...